Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Obstructive Sleep Apnea Syndrome on Metastatic Potential of Cutaneous Melanoma : Prospective Study in Patients With High Risk Melanoma

NCT02699918 is registered in ClinicalTrials.gov with AGIR à Dom as lead sponsor.

NCT NCT02699918
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02699918 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Obstructive Sleep Apnea Syndrome on Metastatic Potential of Cutaneous Melanoma : Prospective Study in Patients With High Risk Melanoma
Lead sponsor
AGIR à Dom
Phase
Phase 1
Overall status
Withdrawn
Start date
December 1, 2015
Completion date
October 1, 2016
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma with a breslow's thickness ≥ 1mm, obstructive sleep apnea syndrome